Skip to content

    Outset Medical (OM) stock price & financials

    View OM earnings calls

    Overview

    Price

    Market Cap

    Sector

    Rank

    Performance71.8% 1Y

    Financials

    Income Statement

    Financial Trajectories

    11
    Quarterly
    MetricQ3 FY24Q4 FY24Q1 FY25Q2 FY25Q3 FY25Q4 FY25Q1 FY26Q2 FY26Trend
    EarningsRevenue
    $28.67M
    $29.47M
    $29.75M
    $31.42M
    $29.43M
    +2.7%
    $28.87M
    -2.0%
    $27.86M
    -6.3%
    $31.64M
    +0.7%
    Stable
    Operating Profit
    -$23.84M
    -$21.86M
    -$16.40M
    -$16.86M
    -$15.81M
    +33.7%
    -$17.63M
    +19.4%
    -$16.92M
    -3.2%
    -$15.68M
    +7.1%
    Strengthening
    Net Profit
    -$27.94M
    -$25.64M
    -$25.78M
    -$18.54M
    -$17.84M
    +36.2%
    -$19.49M
    +24.0%
    -$18.98M
    +26.4%
    -$17.98M
    +3.0%
    Strengthening
    EPS
    $-8.02
    $-3.66
    $-1.04
    $-1.00
    +87.5%
    $-1.03
    +71.9%
    $-0.97
    +6.7%
    Strengthening
    Other Income
    $2.15M
    $2.04M
    $1.98M
    $1.90M
    $1.85M
    -13.7%
    $1.67M
    -18.1%
    $1.53M
    -22.7%
    $1.35M
    -28.8%
    Weakening
    Interest
    $6.07M
    $5.83M
    $3.56M
    $3.48M
    $3.48M
    -42.7%
    $3.44M
    -40.9%
    $3.37M
    -5.4%
    $3.44M
    -0.9%
    Weakening
    Depreciation
    Profit before Tax
    -$27.76M
    -$25.64M
    -$25.67M
    -$18.44M
    -$17.43M
    +37.2%
    -$19.40M
    +24.4%
    -$18.76M
    +26.9%
    -$17.76M
    +3.7%
    Strengthening
    MarginsOPM
    -83.2%
    -74.2%
    -55.1%
    -53.7%
    -53.7%
    +35.4%
    -61.0%
    +17.7%
    -60.7%
    -10.2%
    -49.5%
    +7.7%
    Strengthening
    Tax
    -0.7%
    0.0%
    -0.5%
    -0.6%
    -2.3%
    -251.5%
    -0.5%
    -2550.0%
    -1.2%
    -157.8%
    -1.2%
    -121.4%
    Weakening
    ReturnsROIC
    2.3%
    2.1%
    2.1%
    1.5%
    1.5%
    -36.2%
    1.6%
    -24.0%
    1.6%
    -26.4%
    1.5%
    -3.0%
    Weakening

    Balance Sheet

    Balance Sheet

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    AssetsCash & Equivalents$36.93M$294.97M$182.35M$73.22M$68.51M$124.01M$35.01M$35.01M
    Short-Term Investments
    Total Current Assets$79.65M$345.91M$409.80M$373.64M$291.22M$258.22M$250.88M$227.85M
    Net PP&E$7.89M$23.25M$20.20M$21.99M$18.65M$12.07M$9.47M$8.60M
    Goodwill
    Intangibles
    Total Assets$88.37M$403.83M$463.46M$400.12M$313.80M$275.80M$264.50M$242.38M
    LiabilitiesTotal Current Liabilities$24.91M$36.69M$51.70M$51.95M$55.32M$45.38M$37.63M$43.89M
    Short-Term Debt$7.50M$2.02M$2.02M$4.75M
    Long-Term Debt$21.56M$29.67M$29.76M$96.34M$130.11M$197.38M$96.24M$97.65M
    Long-Term Leases$8.04M$6.89M$5.58M$4.48M$2.68M$3.27M$3.06M
    Total Liabilities$51.11M$75.22M$89.38M$154.13M$190.91M$248.98M$137.54M$146.05M
    EquityCommon Stock & APIC$1.0K$43.0K$47.0K$48.0K$50.0K$4.0K$18.0K$19.0K
    Retained Earnings-$372.57M-$494.06M-$625.99M-$788.95M-$961.75M-$1.09B-$1.17B-$1.21B
    Total Equity-$287.95M-$372.19M$328.61M$374.08M$245.99M$122.89M$26.82M$126.95M$96.34M
    HighlightsNet Cash / (Debt)$7.87M$263.27M$150.56M-$27.86M

    Cash Flow

    Cash Flow

    USD · Annual
    Line itemFY18FY19FY20FY21FY22FY23FY24FY25TTM
    ActivitiesCash from Operating-$46.44M-$70.29M-$99.02M-$130.26M-$145.73M-$131.37M-$116.30M-$46.33M-$38.32M
    Cash from Investing-$68.78M$74.30M$3.95M-$142.51M-$66.30M$83.03M$103.94M-$97.68M$33.62M
    Cash from Financing$134.87M$249.0K$385.68M$160.15M$72.90M$43.65M$67.87M$55.50M$644.0K
    SummaryCapital Expenditure-$1.77M-$3.29M-$9.08M-$3.11M-$8.32M-$3.44M-$912.0K-$798.0K-$559.0K
    Free Cash Flow-$48.21M-$73.58M-$108.09M-$133.37M-$154.05M-$134.81M-$117.22M-$47.13M-$38.88M
    FCF Margin-2402.0%-488.0%-216.5%-130.0%-133.5%-103.4%-103.1%-39.4%-33.0%

    Ratios